Gentian Diagnostics ASOSL:GENT -4.88%72 Quick Ratio is 4.01 as of Mar. 2026, which is 49% below its 10-year median of 7.90. GuruFocus rates OSL:GENT with a GF Score™ of 72/100 and a GF Value™ of kr61.81 (Possible Value Trap). The stock has 1 warning sign investors should review. Among 854 Medical Devices & Instruments companies, Gentian Diagnostics AS ranks better than 77.05% on this metric.
Gentian Diagnostics AS has a quick ratio of 4.01. It generally indicates good short-term financial strength.
The historical rank and industry rank for Gentian Diagnostics AS's Quick Ratio or its related term are showing as below:
OSL:GENT'
s Quick Ratio Range Over the Past 10 Years
Min: 3.78 Med: 7.9 Max: 26.9
Current: 4.01
During the past 13 years, Gentian Diagnostics AS's highest Quick Ratio was 26.90. The lowest was 3.78. And the median was 7.90.
OSL:GENT's Quick Ratio is ranked better than 77.05% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 1.885
vs OSL:GENT: 4.01
Gentian Diagnostics AS (OSL:GENT) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Gentian Diagnostics AS Quick Ratio Related Terms
Gentian Diagnostics AS Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Gentian Diagnostics AS's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gentian Diagnostics AS Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Gentian Diagnostics AS's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Gentian Diagnostics AS's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Gentian Diagnostics AS's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gentian Diagnostics AS (OSL:GENT) has a Quick Ratio of 4.01 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Gentian Diagnostics AS and its competitors. This is 49% below median its historical median of 7.90. Over the past decade, Gentian Diagnostics AS's Quick Ratio has ranged from 3.78 to 26.90. According to the industry distribution chart, Gentian Diagnostics AS ranks #196 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 23%.
Is Gentian Diagnostics AS's Quick Ratio too high?
Gentian Diagnostics AS's current Quick Ratio of 4.01 is 49% below median its 10-year median of 7.90. Over the past 10 years, this metric has ranged from a low of 3.78 to a high of 26.90. The Medical Devices & Instruments industry median Quick Ratio is 1.89. Gentian Diagnostics AS's value of 4.01 is 112.7% above this industry median. Based on the distribution chart, Gentian Diagnostics AS ranks #196 out of 854 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Gentian Diagnostics AS has a GF Score™ of 72/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gentian Diagnostics AS's Quick Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Gentian Diagnostics AS ranks #196 out of 854 companies for Quick Ratio. This places Gentian Diagnostics AS in the top 23% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.89. Gentian Diagnostics AS's value of 4.01 is 112.7% above this benchmark. Historically, Gentian Diagnostics AS's own Quick Ratio has ranged from 3.78 to 26.90 over the past decade. While the company's 10-year median is 7.90 vs. the industry median of 1.89, Gentian Diagnostics AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.89, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gentian Diagnostics AS's current Quick Ratio of 4.01 is 112.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Gentian Diagnostics AS and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gentian Diagnostics AS's current Quick Ratio is 4.01, which is 49% below median its own 10-year median of 7.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gentian Diagnostics AS stock overvalued right now?
Based on GuruFocus' analysis, Gentian Diagnostics AS (OSL:GENT) is currently considered Possible Value Trap. The stock's GF Value™ is kr61.81, compared to a current price of kr37.00 — trading 40.1% below its estimated fair value. The current Quick Ratio is 4.01, which is 49% below median its 10-year median of 7.90 and 112.7% above the Medical Devices & Instruments industry median of 1.89. Gentian Diagnostics AS's overall GF Score™ is 72/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Gentian Diagnostics AS (OSL:GENT), the current Quick Ratio is 4.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gentian Diagnostics AS (OSL:GENT) Overvalued in 2026?
Based on GuruFocus' analysis, Gentian Diagnostics AS stock appears to be undervalued.
The current stock price of kr37.00 is trading 40.1% below its estimated GF Value™ of kr61.81.
GuruFocus considers Gentian Diagnostics AS to be Possible Value Trap.
Key valuation signals for OSL:GENT:
Quick Ratio: 4.01 (49% below median its 10-year median of 7.90)
GF Value™: kr61.81 vs. price of kr37.00 (40.1% below fair value)
Industry Position: 112.7% above the Medical Devices & Instruments median (#196 of 854)
No single metric tells the full story. See the OSL:GENT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gentian Diagnostics AS operates as a medical diagnostics company in Norway. It develops and produces in vitro diagnostic reagents (IVD) for medical diagnostics and research. Its portfolio and pipeline of reagents span areas such as inflammation, severe infections, kidney diseases, heart failure, and veterinary healthcare. The company's product portfolio includes the Gentian Cystatin C Immunoassay, the GCAL circulating calprotectin immunoassay (IVDR), the Gentian Retinol Binding Protein (RBP), and the Gentian Canine CRP, among others. Geographically, it generates a majority of its revenue from Europe, followed by Asia and the United States of America.
72GF Score
Get the complete analysis for OSL:GENT
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSL:GENT has been successfully added to your 
